Director's Share Transfer

Futura Medical PLC
10 January 2008



Draft release                                             10 January 2008


                               Futura Medical plc
                          ('Futura' or 'the Company')

                           Director's Share Transfer

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative
products for consumer healthcare, announces the following transfer of ordinary
shares in the Company by Anthony Clayden, Finance Director. There is no change
in Mr Clayden's total shareholding in the Company, or the beneficial ownership
of Mr Clayden's shares, as a result of the transfer. On 9 January 2008, Mr
Clayden authorised the transfer of 240,305 of his ordinary shares in the Company
into his Hargreaves Lansdown Vantage Fund and Share account.


For further information:
Futura Medical plc
James Barder, Chief Executive                 Tel: [phone]
mail to: [e-mail]     www.futuramedical.co.uk

Media enquiries:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich            Tel: [phone]

Nominated Adviser:
Canaccord Adams Limited
Mark Williams / Erin Needra                   Tel: [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange